Oversold

RGEN

Valuation29/ 100
Cash flow & growth86/ 100
Upside potential51/ 100
Risk potential36/ 100

RGEN's valuation is somewhat elevated while strong fundamentals support the investment case and forward estimates point to improving growth and profitability.

Score change since last week

The score fell 7 points, mainly due to valuation and price changes. Price fell 4.9%, from $176.27 to $167.60.

Valuation and price changes subtracted 7.6 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 226.3× versus the full-history median of 149.1× shown in the valuation table, producing 24.5/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 29.4/100. The model applies a 24% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 161.8× (18-month half-life). The favorable scenario uses 235.6× PE and $1 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +16.5%, earnings +812.5%, operating margin +11.9 percentage points. Free cash flow is 14.1% of revenue. The business score is 86/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $0.97 of EPS and a 235.6× PE, suggesting a share price of about $229.47. Valuation history and outlook inform the PE.

The displayed favorable scenario is 38.9% upside, or about $229.44.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $0.63 of EPS and a 166.6× PE, suggesting a share price of about $105.61 — 36% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

RGEN vs Historical averages

MetricCurrentAverageRelative
PE226x498x55% lower
PE percentile645029% higher
EPS$0.73$1.3546% lower
FCF$110.8M$74.2M49% higher
Loading historical comparisons…

RGEN’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.

RGEN Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsGrowth
Forward revenueGrowth
Forward profitabilityStrongly expanding
Analyst coverageModerate
Estimate dispersionTight

RGEN’s outlook is generally improving, with growth expectations supporting the valuation case.

RGEN PE Valuation

Loading pe valuation table…

This table applies RGEN's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

RGEN Earnings Per Share

Loading earnings per share…

This chart tracks RGEN's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

RGEN Quarterly Revenue

Loading quarterly revenue…

This chart tracks RGEN's quarterly revenue over time and shows how sales are changing from year to year.

RGEN Free Cash Flow

Loading free cash flow…

This chart tracks RGEN's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

RGEN Total Shares

Loading shares over time…

This chart tracks changes in RGEN's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

RGEN Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

RGEN PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares RGEN's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

RGEN Weekly Price

Loading weekly price…

This chart uses RGEN's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

RGEN Weekly Moving Averages

Loading weekly moving averages…

This chart compares RGEN's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

RGEN Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.